Other OTC Healthcare Products Market in Israel to 2014 (OTC Healthcare)

Introduction

This databook provides key data and information on the Other OTC Healthcare Products Market in Israel (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.

Scope

*Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data
*Category level company and brand share as well as distribution share information for 2007 and 2008

Highlights


Other OTC healthcare products category was valued at ILS278.7m ($77.7m) in 2009, representing a CAGR of 2% since 2004.

By the end of 2014, Other OTC healthcare products category will be worth ILS304.7m ($84.9m), with an expected CAGR of 1.8% between 2009 and 2014.

Other OTC healthcare products market was led by rectal medications (representing 32% of the total value) followed by eye /ear drops and sleeping aids, with a 28.1% and 23.8% market share, respectively. Anti-smoking aids and motion sickness constitute the remaining segments with a 10.5% and 5.6% market share, respectively.

GlaxoSmithKline Plc is the market leader with a 16.7% share of the market.


Reasons to Purchase

*Develop business strategies by understanding the quantitative trends within the Other OTC Healthcare Products Market in Israel (OTC Healthcare)

*Design effective marketing and sales strategies by identifying key market categories and segments

*Identify key players within the market to plan lucrative M&A, partnerships and agreements

[Studien Infos ausblenden]

TABLE OF CONTENTS
Chapter 1 Executive Summary 2
Summary category level: other OTC healthcare products 2
Chapter 2 Definition 3
Chapter 3 Category Analysis: Other OTC Healthcare Products 8
Value analysis (Israeli New Shekel), 2004?09 8
Value analysis (Israeli New Shekel), 2009?14 9
Value analysis (US dollars), 2004?09 11
Value analysis (US dollars), 2009?14 12
Company and brand share analysis 14
Distribution analysis 19
Chapter 4 Macroeconomic Profile 21
Macroeconomic Indicators 21
Chapter 5 Research Methodology 26
Methodology overview 26
Secondary research 27
Market modeling 28
Creating an initial data model 28
Revising the initial data model 28
Creating a final estimate 29
Creating demographic value splits 29
Primary research 29
Data finalization 30
Ongoing research 30

LIST OF FIGURES
Figure 1: Other OTC healthcare products, Israel, value by segment (ILSm), 2004?14 10
Figure 2: Other OTC healthcare products, Israel, category growth comparison, by value, 2004?14 13
Figure 3: Other OTC healthcare products, Israel, company share by value (%), 2008?09 16
Figure 4: Other OTC healthcare products, Israel, distribution channels by value (%), 2008?09 20
Figure 5: Annual data review process 27

LIST OF TABLES
Table 1: Other OTC health care products category definitions 3
Table 2: Other OTC health care products distribution channels 4
Table 3: Other OTC healthcare products, Israel, value by segment (ILSm), 2004?09 8
Table 4: Other OTC healthcare products, Israel, value forecast by segment (ILSm), 2009?14 9
Table 5: Other OTC healthcare products, Israel, value by segment ($m), 2004?09 11
Table 6: Other OTC healthcare products, Israel, value forecast by segment ($m), 2009?14 12
Table 7: Other OTC healthcare products, Israel, brand share by value (%), 2008?09 14
Table 8: Other OTC healthcare products, Israel, value by brand (ILSm), 2008?09 15
Table 9: Other OTC healthcare products, Israel, company share by value (%), 2008?09 17
Table 10: Other OTC healthcare products, Israel, value by company (ILSm), 2008?09 18
Table 11: Other OTC healthcare products, Israel, distribution channels by value (%), 2008?09 19
Table 12: Other OTC healthcare products, Israel, value by distribution channel (ILSm), 2008?09 19
Table 13: Israel population, by age group, 2004?09 (millions) 21
Table 14: Israel population forecast, by age group, 2009?14 (millions) 22
Table 15: Israel population, by gender, 2004?09 (millions) 22
Table 16: Israel population forecast, by gender, 2009?14 (millions) 23
Table 17: Israel nominal GDP, 2004?09 (ILSbn, nominal prices) 23
Table 18: Israel nominal GDP forecast, 2009?14 (ILSbn, nominal prices) 23
Table 19: Israel real GDP, 2004?09 (ILSbn, 2000 prices) 24
Table 20: Israel real GDP forecast, 2009?14 (ILSbn, 2000 prices) 24
Table 21: Israel real GDP, 2004?09 ($bn, 2000 prices) 24
Table 22: Israel real GDP forecast, 2009?14 ($bn, 2000 prices) 25
Table 23: Israel consumer price index, 2004?09 (2000=100) 25
Table 24: Israel consumer price index, 2009?14 (2000=100) 25


[Inhaltsverzeichnis ausblenden]